Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
C-CRISP: Concurrent Chemoradiotherapy with IMRT and Docetaxel-Cisplatin in NSCLC
NCT01266512Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jan 2011
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Sanofi. Started Jan 2011; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01266512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01266512.